Preliminary Evaluation of the Diagnostic Usefulness of Uroplakin 2 with an Assessment of the Antioxidant Potential of Patients with Bladder Cancer

Table 5

Correlations between UP2 and parameters of antioxidative status in BC group.

R	UP2; (urine)	UP2; (plasma)	GSH; (plasma)	TAC; (urine)
UP2; (urine)	-	0.206	-0.081	-0.105
UP2; (plasma)	0.206	-	0.278	0.293
GSH; (plasma)	-0.081	0.278	-	0.221
TAC; (urine)	-0.105	0.293	0.221	-

: positive significant correlations between markers.